Tag: regulatory inspection

Identifying and Addressing Gaps in Ongoing Stability Programs for Generic Drug Products Generic drug products must adhere to stringent stability requirements to ensure quality throughout their shelf life. However, ongoing…

Managing Stability Issues for Discontinued or Low-Volume Pharmaceutical Products In recent times, the pharmaceutical sector has faced challenges regarding the ongoing stability of discontinued or low-volume products. Many organizations struggle…

Addressing Gaps in Ongoing Stability Programs and Quality Review Processes Stability program gaps can significantly impact product quality and regulatory compliance, leading to potential recalls or sanctions by regulatory bodies.…

Defining Representative Batch Selection to Address Gaps in Ongoing Stability Programs In the complex landscape of pharmaceutical manufacturing, maintaining the stability of products is crucial. An effective ongoing stability program…

Addressing Gaps in Ongoing Stability Programs in Pharmaceutical Contract Manufacturing In pharmaceutical manufacturing, the integrity of stability programs is crucial for maintaining product quality and regulatory compliance. Ongoing stability program…

Leveraging Stability Data to Enhance Shelf-Life Management In the fast-paced world of pharmaceutical manufacturing, it is crucial to ensure the proper management of shelf-life through ongoing stability data. Ongoing stability…

Identifying and Addressing Gaps in Ongoing Stability Programs for Cold Chain Products In pharmaceutical manufacturing, ensuring the stability of products throughout their intended shelf life is paramount, especially for cold…

Managing Ongoing Stability for Products Amidst Packaging Changes Maintaining product stability is critical for pharmaceutical manufacturers, especially when changes in packaging occur. Such modifications can lead to significant challenges in…

Addressing Ongoing Gaps in Stability Programs Following a Manufacturing Site Transfer The transfer of manufacturing sites in the pharmaceutical industry is a multi-faceted process that can often lead to ongoing…

Leveraging Stability Results for Informed Change Control Decisions In the pharmaceutical industry, ongoing stability program gaps can pose significant challenges to regulatory compliance and product quality. Practitioners often face the…

Addressing Ongoing Gaps in Stability Programs Identified During FDA Inspections Ongoing stability program deficiencies can significantly impact regulatory compliance, product quality, and ultimately, patient safety. Recently, FDA inspections have highlighted…

Effective Investigation of Delayed or Missed Ongoing Stability Time Points In the highly regulated pharmaceutical industry, the integrity of stability studies is paramount. Delays or missed time points in ongoing…